Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease

Hepatology

Volumn 35, Issue 2, 2002, Pages 433-439

  Forton, Daniel M ^a,b   Thomas, Howard C ^a   Murphy, Christine A ^a   Allsop, Joanna M ^b   Foster, Graham R ^a   Main, Janice ^a   Wesnes, Keith A ^c   Taylor Robinson, Simon D ^a,b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c CDR House ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATININE;

ADULT; AGED; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FACTORIAL ANALYSIS; FATIGUE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER DISEASE; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOMETRY; QUALITY OF LIFE; SCORING SYSTEM; VIREMIA; WHITE MATTER; WORKING MEMORY;

EID: 0036156909     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.30688     Document Type: Article

References (44)

1. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium
2. The role of liver biopsy in chronic hepatitis C
3. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis
4. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group
5. Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection
6. Depression, fatigue, and functional disability in patients with chronic hepatitis C
7. Serum cytokine values and fatigue in chronic hepatitis C infection
8. Evidence for a cerebral effect of the hepatitis C virus
9. HMR spectroscopy of the brain in HIV-1-seropositive subjects: Evidence for diffuse metabolic abnormalities
10. Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex
11. Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients
12. Histopathology of hepatitis C virus infection
13. Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy
14. Efficacy of rivastigmine in dementia with Lewy bodies: Results of a randomised placebo-controlled international study
15. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in middle-age volunteers
16. Assessment of depression: The depression inventory
17. The hospital anxiety and depression scale
18. Development of a fatigue scale
19. Dementia: The estimation of premorbid intelligence levels using the New Adult Reading Test
20. 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline
21. Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy
22. Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy
23. Gender effects on persistent cerebral metabolite changes in the frontal lobes of abstinent cocaine users
24. 1HMRS
25. Brain metabolite changes in alcoholism: An in vivo proton magnetic resonance spectroscopy (MRS) study
26. Neuropsychological functioning in chronic fatigue syndrome: A review
27. The HNRC 500 - Neuropsychology of HIV infection at different disease stages
28. Basal ganglia output and cognition: Evidence from anatomical, behavioral, and clinical studies
29. Hepatitis C virus and depression in drug users
30. The hippocampus in patients treated with electroconvulsive therapy: A proton magnetic resonance spectroscopic imaging study
31. Compounds containing cytosolic choline in the basal ganglia: A potential biological marker of true drug response to fluoxetine
32. Proton MR spectroscopy in multiple sclerosis: Value in establishing diagnosis, monitoring progression, and evaluating therapy
33. The neuropathology of adult HIV infection
34. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: Influence of viral load, viral genotype, and cell phenotype
35. Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets
36. Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver
37. Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: Confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication
38. The microglial cell. A historical review
39. Turnover of resident microglia in the normal adult mouse brain
40. Penetration of neurotrophins and cytokines across the blood-brain/blood-spinal cord barrier
41. Cytokines and the brain: Implications for clinical psychiatry
42. Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre- and posttreatment with interferon alfa